Whitlock J P, Denison M S, Fisher J M, Shen E S
Department of Pharmacology, Stanford University School of Medicine, CA 94305.
Mol Biol Med. 1989 Apr;6(2):169-78.
The halogenated aromatic hydrocarbon 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a persistent, widespread, potentially toxic environmental contaminant, which is a potent inducer of aryl hydrocarbon hydroxylase activity in the liver and other tissues. TCDD induces hydroxylase activity by increasing the rate of transcription of the CYP1A1 gene. Activation of CYP1A1 transcription requires the binding of TCDD to an intracellular protein, the Ah receptor, followed by the binding of the liganded receptor to a dioxin-responsive enhancer that is located upstream from the CYP1A1 gene. The liganded receptor recognizes a specific DNA sequence, which is present in multiple copies within the enhancer. The receptor-enhancer interaction occurs within the major groove of the DNA helix. DNA methylation in vitro interferes with the receptor-enhancer interaction and, therefore, has the potential to inhibit the biological response to TCDD.
卤代芳烃2,3,7,8-四氯二苯并对二恶英(TCDD,二恶英)是一种持久、广泛存在且具有潜在毒性的环境污染物,它是肝脏和其他组织中芳烃羟化酶活性的强效诱导剂。TCDD通过提高CYP1A1基因的转录速率来诱导羟化酶活性。CYP1A1转录的激活需要TCDD与细胞内蛋白芳烃受体(Ah受体)结合,随后配体化的受体与位于CYP1A1基因上游的二恶英反应增强子结合。配体化的受体识别特定的DNA序列,该序列在增强子中以多个拷贝存在。受体与增强子的相互作用发生在DNA螺旋的大沟内。体外DNA甲基化会干扰受体与增强子的相互作用,因此有可能抑制对TCDD的生物学反应。